Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA modelsfeatured in two peer-reviewed articles
This Fast Track Designation will enable FDA to review MM-II in an expedited manner, is an important milestone in the development of MM-II
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Apremilast Tablets, 10 mg, 20 mg, and 30 mg is a generic equivalent of reference listed drug (RLD) OTEZLA of Celgene.
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane
UCB plans to submit regulatory applications in Q3 2022
It is the first monoclonal antibody drug for use in any animal species
Subscribe To Our Newsletter & Stay Updated
